-
Product Insights
Rheumatoid Arthritis - Global Clinical Trials Review, 2026
Understand the Global Clinical Trials Landscape for Rheumatoid Arthritis Rheumatoid arthritis remains a key focus area in global clinical research, with ongoing trials shaping the future of treatment and innovation. This report provides a comprehensive snapshot of the global clinical trials landscape, covering trial activity across regions, countries (G7 & E7), phases, statuses, endpoints, and sponsor types. As a result, you gain a clear understanding of where research is accelerating and how the competitive landscape is evolving. Report Value Proposition...
-
Thematic Analysis
Antibody-Drug Conjugate (ADC) Drug Landscape: Historical, Current, and Emerging Therapies
This report investigates the impacts and development of Antibody-Drug Conjugate therapies within the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes within the market and how best to pivot to prioritize future changes in the market.
-
Sector Analysis
Atopic Dermatitis: 68-Market Analysis and Drug Forecast to 2033
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Atopic Dermatitis disease market through 2033. GlobalData estimated that the atopic dermatitis market was $10.8 billion across the 68MM in 2023. By the end of the forecast period in 2033, sales across these markets will reach $26.2 billion, increasing at a compound annual growth rate (CAGR) of 9.3%. This strong growth will be fuelled by driven by the launch of seven late-stage pipeline agents in...
-
Sector Analysis
Atopic Dermatitis Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033
This report covers the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report provides an overview of the current treatment options, pipeline products in development, as well as current and future R&D trends. Key topics covered include a strategic competitive assessment of current and future drugs, unmet needs, KOL insights, and implications for the Atopic Dermatitis market. The base year of the sales forecast model is 2023, and the forecast period is 2023-2033. GlobalData estimated...
-
Analyst Opinions
Biocomputing: Market Trends and Innovations
Biocomputing is transitioning from a research-led concept into a deployable computing paradigm, where computation is executed through molecular and cellular processes rather than electronic circuits. The latest Innovation Radar: Biocomputing report examines how biology is being engineered as a programmable execution layer, capable of storing information, processing logic, and generating outputs directly within biological environments. At the core of this shift is a maturing biocomputing stack that integrates biological substrates with digital infrastructure. Computation is encoded in DNA, RNA, proteins,...
-
Sector Analysis
Retinitis Pigmentosa: Market View, Current and Future Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in Retinitis Pigmentosa Therapeutics. • In 2024 and 2029, China is anticipated to have the highest number of diagnosed prevalent cases of RP, representing a large portion of global cases. • Currently, the RP market is largely reliant on off-label and symptomatic approaches. • The RP pipeline holds 102 molecules, with no assets in the pre-registration stage, four assets in Phase III development, and another 21 in...
-
Product Insights
Clinical Trials: What to Expect in 2026 - A Preview of Trials Planned to Initiate and Estimated to Complete
Clinical Trials: What to Expect in 2026? Planned and completing trials by phase, geography, sponsor type, therapy area, and DCT adoption. Identify pipeline trends and benchmark competitors with GlobalData insights.
-
Sector Analysis
Crohn's Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Crohn’s Disease Drug Market Forecast and Competitive Intelligence Across the 8MM GlobalData’s Crohn’s Disease market report provides detailed analysis of the therapeutics landscape across the eight major markets (8MM), combining market forecasts, pipeline intelligence, competitive assessment, and treatment usage insights through 2032. The report highlights that Crohn’s Disease drug sales across the 8MM are expected to increase from $9.5 billion to $13.8 billion by 2032, reflecting a CAGR of 3.9%. Growth is supported by the approval and launch of eight...
-
Product Insights
Gastroesophageal (GE) Junction Carcinomas - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Gastroesophageal (GE) Junction Carcinomas - Global Clinical Trials Review, 2025" provides an overview of Gastroesophageal (GE) Junction Carcinomas Clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroesophageal (GE) Junction Carcinomas. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2025" provides an overview of Cutaneous Squamous Cell Carcinoma (cSCC) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Squamous Cell Carcinoma (cSCC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.